Srihari Veeraraghavan is a Respiratory physician affiliated with Emory University. OpenAlex indexes 72 publications with 5,217 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE
Bldg A, 4th Floor
Atlanta, GA 303221013
Telephone
404-778-5736Registry record last updated 10 Sept 2015.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202316 payments
- United Therapeutics CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
49.1%Corticosteroid23.9%Trelegy Ellipta34%Symbicort24%Fluticasone Propionate14%Breo Ellipta10%Fluticasone Propionate Hfa6%Budesonide-Formoterol Fumarate6%Breztri Aerosphere6%Part D<11 patientsbeta2-Adrenergic Agonist19.9%Albuterol Sulfate Hfa88%Ventolin Hfa12%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
23.4%Corticosteroid12.7%Prednisone100%Part D≥53 patientsProton pump inhibitor8.3%Omeprazole73%Pantoprazole Sodium27%Part D<11 patients+ 1 more class in this area
Cancer & immunology
15.7%Kinase inhibitor10.1%Ofev88%Everolimus12%Part D<11 patientsFolate Analog Metabolic Inhibitor3.2%Methotrexate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Craig Hofmeister, MD
Emory University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”